trial · primary record
Claseprubart
Chronic Inflammatory Demyelinating Polyneuropathy
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 256 |
| Primary completion | 2030-12-31 |
| Primary endpoint | Part B: Time From First Dose to Relapse as Assessed by the Adjusted Inflammatory Neuropathy Cause and Treatment (INCAT) |
| Registry ID | NCT06858579 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:43:09.280Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06858579
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Claseprubart · compound